Wang Lab

The Wang lab is interested in developing drug leads/candidates for kinase, phosphate kinase and protein targets identified by UNC faculty and external investigators. We have successfully used the structure- and/or ligand-based drug design approaches to deliver compounds to clinic (MerTK inhibitors such as MRX-2843) or licensing (IDH1 inhibitor, co-developed with NCATs). We will continue to apply the similar approaches for drug discovery towards new targets.

Xiaodong Wang, PhD

Associate Professor, Chemical Biology and Medicinal Chemistry
Director of Medicinal Chemistry
xiaodonw@unc.edu

Ivie Conlon, PhD

Postdoc
iviecon@email.unc.edu

Shiva Guduru, PhD

Postdoc
shivag@email.unc.edu

Megan Hopkins, PhD

Postdoc
mdh1992@email.unc.edu

Deyu Kong, PhD

Postdoc
deyu2@email.unc.edu

Yubai Zhou, PhD

Postdoc
zhouyb@email.unc.edu